Zolmitriptan 139264-17-8
1 Inquiries
139264-17-8
Shanghai
as required
2025-08-30
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Zolmitriptan
Other Name:2-Oxazolidinone,4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-,(4S)-;2-Oxazolidinone,4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-,(S)-;(4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone;Zolmitriptan;311C90;(S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone;BW 311C90;Zomig;Asco Top;(4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one;Xolnox;Zominat;Zipton;No-migraine Z;Amigrawest;(4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one;2-Oxazolidinone 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-,(4S)-
CAS No.:139264-17-8
Molecular Formula:C16H21N3O2
InChIKeys:InChIKey=ULSDMUVEXKOYBU-ZDUSSCGKSA-N
Molecular Weight:287.36
Exact Mass:287.36
EC Number:1806241-263-5
UNII:2FS66TH3YW
NSC Number:760383
DSSTox ID:DTXSID8045933
NCI Thesaurus Code:C47789
ATC Code:N02CC03|N - Nervous system
HScode:29349990
Categories:
Characteristics-
PSA:
57.4
XLogP3:2.2
Appearance:white to beige
Density:1.217±0.06 g/cm3(Predicted)
Melting Point:136-141°C
Boiling Point:563.3±38.0 °C(Predicted)
Flash Point:294.5±26.8 °C
Refractive Index:1.620
Water Solubility:Soluble in DMSO at 5mg/ml
Storage Conditions:Refrigerator
Vapor Pressure:1.03E-12mmHg at 25°C
Specific rotation:D22 -5.79° (c = 0.5 in methanol)
Dissociation Constants:9.64
Collision Cross Section:160.6 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]|159.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Specific target organ toxicity â single exposure, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H371 May cause damage to organs
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P308+P316 IF exposed or concerned: Get emergency medical help immediately.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
India
Zolmitriptan
25 G Jul 29, 2025 Post an enquiry for this product